SPAC Daily: Double Deal Termination Adds to the Growing List as Q2 Ends

by | Jun 30, 2022

Plus the rest of the day’s news in SPACs

The first half of 2022 has punished just about everyone in the market, but especially those in SPAC land. Our monthly SPAC Market Review will be released tomorrow and we’ll go in depth across SPACs, but today’s after hours double deal termination typifies the market year-to-date.

Today’s FTCV and ISLE deal terminations make it 9 for the month of June. ISLE was the smaller of the two deals and the merger with Cytovia Therapeutics was valued around $370M at the time it was announced. The FTCV / eToro deal was substantially larger. Original deal valuation was $10B, but given how the market has eroded broadly and newcomers like HOOD and COIN are down -54% and -81% respectively, it’s not a surprise to see the deal fall through.

Another 9 SPAC deals terminated in June 2022. Source: Boardroom Alpha

Elsewhere in SPACs

  • Looking forward, the SPAC calendar is dominated by extension votes. And, for those deal votes still upcoming, investors will certainly have their doubts about deals coming to completion.
  • Apollo pulled Spartan IV (SRTN) with a registration withdrawal today, but still has APGB and ACRO looking for deals.
Apollo’s SPAC sponsor performance summary. Source: Boardroom Alpha
  • Enjoy Technology Inc (ENJY) which deSPAC’d in October 2021 has already filed for chapter 11 bankruptcy.
  • Digital World Acquisition (DWAC) popped +7%, on no news, but at $24.16 remains down -53% YTD.
  • Northern Lights (NLIT) surged over $25 during the day, but settled and closed the day up 9% at $10.61. Shareholders approved the merger on the 28th of June and today it extended the deadline to consummate the merger to September 28, 2022.
  • deSPACs continued to suffer with Polestar (PSNY — ex-GGPI) dropping -10% to $8.81. DAVE, which started trading below $1 in early June dropped another -8% and is now at just $0.69. MSPR dropped -14% and is now at $2.14.
More deSPAC pain on the last day of June. Source: Boardroom Alpha

June’s deSPACs Feel the Pain

Source: Boardroom Alpha

SPAC Calendar

SPAC deal terminations are starting to pile up. Source: Boardroom Alpha

Today’s SPAC Stock Movers

Biggest Gainers

9.38% ~ $ 10.61 | NLIT – Northern Lights Acquisition Corp. (Announced)
7.04% ~ $ 24.16 | DWAC – Digital World Acquisition Corp. (Announced)
1.58% ~ $ 10.29 | REVE – Alpine Acquisition Corp. (Announced)
.92% ~ $ 9.84 | GBBK – Global Blockchain Acquisition Corp. (Pre-Deal)
.90% ~ $ 10.04 | HCMA – HCM Acquisition Corp (Pre-Deal)
.80% ~ $ 10.02 | KNSW – KnightSwan Acquisiton Corp (Pre-Deal)
.72% ~ $ 9.81 | GLHA – Glass Houses Acquisition Corp. (Pre-Deal)
.70% ~ $ 10.05 | HHGC – HHG Capital Corporation (Pre-Deal)
.61% ~ $ 9.87 | NHIC – NewHold Investment Corp. II (Pre-Deal)
.60% ~ $ 10.07 | RACY – Relativity Acquisition Corp (Pre-Deal)
.51% ~ $ 9.82 | MACA – Moringa Acquisition Corp (Announced)
.51% ~ $ 9.83 | MDH – MDH Acquisition Corp. (Pre-Deal)
.50% ~ $ 9.97 | MBSC – M3-Brigade Acquisition III Corp. (Pre-Deal)
.50% ~ $ 10.00 | PIAI – Prime Impact Acquisition I (Pre-Deal)
.50% ~ $ 10.06 | TRON – Corner Growth Acquisition Corp. 2 (Pre-Deal)
.50% ~ $ 10.13 | MEOA – Minority Equality Opportunities Acquisition Inc. (Pre-Deal)
.46% ~ $ 9.80 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
.45% ~ $ 10.06 | RNER – Mount Rainier Acquisition Corp. (Announced)
.41% ~ $ 9.86 | AGCB – Altimeter Growth Corp. 2 (Pre-Deal)
.41% ~ $ 9.91 | VCXA – 10X Capital Venture Acquisition Corp. II (Announced)

Biggest Losers

-1.03% ~ $ 9.87 | PEPL – PepperLime Health Acquisition Corp (Pre-Deal)
-1.00% ~ $ 9.90 | MEKA – MELI Kaszek Pioneer Corp (Pre-Deal)
-.80% ~ $ 9.86 | BHAC – Crixus BH3 Acquisition Corp. (Pre-Deal)
-.80% ~ $ 9.92 | LGTO – LEGATO MERGER CORP. II (Announced)
-.71% ~ $ 9.77 | LDHA – LDH Growth Corp I (Pre-Deal)
-.69% ~ $ 10.03 | IFIN – InFinT Acquisition Corporation (Pre-Deal)
-.61% ~ $ 9.74 | GGMC – Glenfarne Merger Corp. (Pre-Deal)
-.60% ~ $ 9.86 | AIMA – Aimfinity Investment Corp. I (Pre-Deal)
-.52% ~ $ 9.61 | LOCC – Live Oak Crestview Climate Acquisition Corp. (Pre-Deal)
-.51% ~ $ 9.67 | ACRO – Acropolis Infrastructure Acquisition Corp. (Pre-Deal)
-.51% ~ $ 9.68 | CORS – Corsair Partnering Corporation (Pre-Deal)
-.51% ~ $ 9.71 | GFOR – Graf Acquisition Corp. IV (Pre-Deal)
-.51% ~ $ 9.77 | PTOC – Pine Technology Acquisition Corp. (Pre-Deal)
-.51% ~ $ 9.79 | BOAS – BOA Acquisition Corp. (Announced)
-.50% ~ $ 9.89 | SAGA – Sagaliam Acquisition Corp (Pre-Deal)
-.50% ~ $ 9.92 | DECA – Denali Capital Acquisition Corp. (Pre-Deal)
-.50% ~ $ 9.92 | PORT – Southport Acquisition Corporation (Pre-Deal)
-.46% ~ $ 9.76 | PANA – Panacea Acquisition Corp. II (Pre-Deal)
-.41% ~ $ 9.66 | TPBA – TPB Acquisition Corporation I (Pre-Deal)
-.41% ~ $ 9.76 | RONI – Rice Acquisition Corp. II (Pre-Deal)

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

SPAC Market Review – July 2022

Liquidations, cancelled deals, and a dead IPO market highlight Boardroom Alpha’s July 2022 SPAC market review. Read for a full recap.

SPAC Market Review – June 2022

Boardroom Alpha’s June 2022 SPAC market review looks at the latest trends in SPACs, where the market is heading a recap of activity.

SPAC Market Review – May 2022

Inflation, rising interest rates, and reduced corporate earnings across the board have led to persistent market gyrations which prove its too early for bottom fishing. The stampede out of deSPACs now makes it ‘deal-or-die’ time for those without targets.

SPAC Research & Analysis

Boardroom Alpha Digest: Mon, Jan 9

Rite Aide Corporation (RAD) parts ways with Heyward Donigan and Paya Holdings (PAYA) acquisition highlight Monday’s daily digest.

Boardroom Alpha Digest: Thurs, Jan 5

Boardroom Alpha’s Daily Digest highlights include Elizabeth Spaulding resigning as CEO of Stitch Fix (SFIX) and JNJ’s Kenvue filing for an IPO

SPAC Market Review – December 2022

December’s SPAC market review takes a look by the numbers of the month’s SPAC activity and how the market currently stands going into 2023.

SPACs Today: Wednesday, Dec 14

Rice Acquisition Corp. II (RONI) with an encouraging energy transaction, and the rest of the day’s SPAC news.

SPACs Today: Monday, Dec 12

Venus Acquisition Corporation (VENA) finally closed and changes ticker to MLGO, and the rest of the day’s SPAC news.

SPAC Market Review – November 2022

November’s SPAC market review paints a picture of a SPAC market rushing towards the exit with high, and accelerating liquidations, more deal terminations, and almost no new SPAC IPOs.

Know Who Drives Return Podcast

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. WindAcre increases its stake and opposes NSLN takeover bid. Activist Jana Partners brings lessons learned at ConAgra (CAG) to Treehouse Foods (THS). And other notable special situations.

Boardroom Alpha Daily Read

We take a look at the day’s news, ESG trends and special situations. Management shakeup at Faraday Future (FIFE) is an all-too familiar story in the world of EV SPACs. Blackrock to be 75% net-zero aligned by 2030, and Jana closing in (again) at Treehouse Foods (THS).

FOXO Technologies CEO Jon Sabes Is About to Disrupt the Insurance Industry

Boardroom Alpha talks to Jon Sabes, CEO of FOXO Technologies, which announced a SPAC merger with sponsor Delwinds Insurance Acquisition Corp. (DWIN). Sabes explains how epigenetic biomarkers can change the game for life insurance companies and tell us more about health and wellness than ever before.


The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.